Header Logo

Connection

Michael Liptay to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Michael Liptay has written about Radiopharmaceuticals.
Michael Liptay
Connection Strength
1.157
Radiopharmaceuticals
  1. Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. J Thorac Oncol. 2009 Feb; 4(2):198-202.
    View in: PubMed
    Score: 0.338
  2. Sentinel node mapping in lung cancer: the Holy Grail? Ann Thorac Surg. 2008 Feb; 85(2):S778-9.
    View in: PubMed
    Score: 0.316
  3. Sentinel lymph node mapping in lung cancer. Cancer Treat Res. 2005; 127:141-50.
    View in: PubMed
    Score: 0.255
  4. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000 Aug; 70(2):384-9; discussion 389-90.
    View in: PubMed
    Score: 0.188
  5. Sentinel node mapping in lung cancer. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):271S-4S.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.